Potassium N-heterobiaryltrifluoroborates were successfully prepared via a selective Cu-catalyzed C-N coupling reaction. The BF3K moiety was well tolerated under the reaction conditions involving CuI and dimethylethylenediamine (DMEDA) in the presence of DMSO. The Pd-catalyzed Suzuki-Miyaura cross couplings of potassium N-heterobiaryltrifluoroborates with bromoarenes were studied to prepare the N-heterotriaryl compounds. Moreover, homocoupling, iodination, and hydroxylation of potassium N-heterobiaryltrifluoroborates provided the corresponding products in high yields.
Introduction N-Heterobiarenes are ubiquitous in many bioactive natural products, 1 pharmaceutical drugs, 2 and organic materials.
3
For example, Tepoxalin, a N-aryl pyrazole derivative, has been reported as a novel dual inhibitor of COX (COX-1 and COX-2) and LOX. 4 DPC-423, developed by Bristol Myers Squibb, shows antithrombotic effects in human plasma.
5 The parent compound of Meribendan, CI 930 inhibits the action of the phosphodiesterase enzyme PDE3 (Scheme 1).
One of the most powerful synthetic methods to prepare Nheterobiarenes is the Cu-catalyzed C-N coupling reaction.
7
A large number of this Ullmann-type coupling reaction with various coupling partners (nucleophiles), including not only arylhalides but also arylboronic acids and aryltrifluoroborates, have been reported. Particularly, Cu-catalyzed C-N bond formation employing the arylboronic acids as a coupling partner are known as the Chan-Lam coupling and it has been widely demonstrated by various research groups.
8
Sreedhar and co-workers developed a Cu 2 O-catalyzed C-N cross-coupling of arylboronic acids with N-heteroarenes.
8c Surprisingly, bromophenylboronic acids and imidazole were used as coupling partners, bromo-substituted N-heterobiarene was obtained as a major product. Moreover, Batey and co-workers reported that potassium aryltrifluoroborates could be utilized in Cu(OAc) 2 -catalyzed C-N bond coupling.
8d However, to the best of our knowledge, there is no reports on the preparation of the potassium N-heterobiaryltrifluoroborates by the selective Cu-catalyzed Ullmann-type reaction with halobenzene derivatives bearing a BF 3 K moiety on the phenyl ring.
Over the last decade, organotrifluoroborate salts have attracted a great deal of attention because of their excellent air and moisture stability as well as their remarkable tolerance to harsh conditions in numerous synthetic reactions. For instance, direct functionalizations of organotrifluoroborates via epoxidation, 9a Jones oxidation, 9b Wittig olefination, 9c click reaction 9d or halogen-lithium exchange 9e have been successfully performed without elimination of the BF 3 K group. In addition, numerous transformations of the BF 3 K group in the reactions, such as Suzuki-Miyaura coupling, halogenation, 10 hydroxylation, 11 and C-N bond formation 8d have been investigated. Developing a synthetic method employing various organotrifluoroborate, thus, would be important for expanding the scope of organotrifluoroborate chemistry. In here, we report the synthesis of potassium N-heterobiaryltrifluoroborates using the selective Cu-catalyzed Ullmann-type condensation a These authors contributed equally to this work. Scheme 1. Selected examples of the biologically active N-heterobiarenes.
Scheme 2. Our synthetic route for the selective preparation of Nheterobiaryltrifluoroborates.
of halophenyltrifluoroborates with N-heteroarenes (Scheme 2).
Results and Discussion
We first focused on the synthesis of potassium 4-(1H-pyrazolyl)phenyltrifluoroborate (1a) employing potassium 4-iodoaryltrifluoroborate with pyrazole (Table 1) .
12
In our previous study, 13 we found that Cu-catalyzed azidation of potassium 4-haloaryltrifluoroborates could be effective without loss of the BF 3 K moiety. N,N'-Dimethylethylenediamine (DMEDA) was the best ligand among all the amine ligands tested, and it provided the highest conversion yield in shortest time. Thus, DMEDA was chosen as the ligand in the present study and the reaction was carried out in DMSO-d 6 in an NMR tube. The reaction was monitored by 1 H NMR. Various catalysts, including Cu(I) and Cu(II) salts were screened for the C-N bond formation (Table 1 , entries 1-6). The reactions were carried out in the presence of Cu (II) catalyst such as Cu(acac) 2 and Cu(OAc) 2 (Table 1 , entries 1 and 2). However, the reactions did not complete even after heating at 120 °C for 4 h. In contrast, the reaction proceeded at a faster rate in the presence of CuBr or CuO 2 , and full conversion was observed within 4 h. Nevertheless, the best catalyst was CuI as it afforded the product in excellent isolated yield (Table 1 , entry 6) in 2 h. Test reactions using a variety of bases (cf. Cs 2 CO 3 , K 3 PO 4 , K 2 CO 3 , NaOtBu, and KOtBu) indicated Cs 2 CO 3 to be the best (Table  1, entries 6-10) . The reaction rate decreased considerably when the reaction temperature was lowered to 100 °C (Table 1, entry 11).
We applied these optimized conditions to various nitrogencontaining heteroarenes to explore the scope of the CuIcatalyzed coupling reaction (Table 2) . In most cases, the desired potassium N-heterobiaryltrifluoroborates were obtain- ed in good to excellent yields. However, coupling of 2-iodoaryltrifluoroborate and pyrazole furnished the product 1c in 40% yield, probably due to the steric effect (Table 2 , entry 3). Two regioisomers, 1e and 1f were obtained when 3-methylpyrazole was used as the coupling partner due to the electron-donating effect of the methyl group (Table 2 , entry 5).
14 Moreover, the regioisomers (1g/1h, 1l/1m, and 1n/1o) were obtained in a ratio of 2:1 to 8:1 when 1,2,3-triazole, indazole, and benzotriazole were used as the coupling partners (Table 2, entries 6, 10 and 11) .
N-arylpyrazoles are well known core framework in drug development.
2 For example, Rimonabant, 15 an anorectic antiobesity drug, and Celecoxib, 16 a sulfa-NSAID, commonly contain the N-arylpyrazole skeleton. In our ongoing project, we also studied on the synthesis of biologically active compound libraries including the N-arylpyrazole core. We were interested in the functionalization of N-arylpyrazole compounds bearing a BF 3 K moiety by Suzuki-Miyaura cross coupling with bromoarenes. Under the optimized conditions that we developed, 17 we conducted the cross coupling reaction of potassium 4-or 3-(1H-pyrazolyl)-phenyltrifluoroborate (1a or 1b) with bromoarenes bearing various functional groups. As illustrated in Table 3 , all the reactions proceeded to 100% completion within 1 h to afford the desired Nheterotriaryl compounds in good to excellent yields.
Finally, we further attempted functionalization reactions of 1a towards homocoupling, iodination, and hydroxylation. The results are summarized in Scheme 3. Homocoupling of 1a under the same conditions used for cross coupling without bromoarenes afforded the desired homocoupled product 3 in 90% yield. Iodination 10 of the BF 3 K group of 1a was also successfully accomplished to give the product 4 in 90% yield. Furthermore, hydroxylation 11 of 1a using oxone gave the corresponding phenol derivative 5 in high yield.
Conclusion
In summary, Cu-catalyzed functionalization of potassium iodoaryltrifluoroborates with N-heteroarenes was successfully accomplished without loss of the BF 3 K moiety. The intact BF 3 K moiety could be further utilized in SuzukiMiyaura cross coupling to afford N-heterotriaryl compounds. F NMR spectra were recorded at 400, 100, and 376 MHz, respectively.
19
F NMR chemical shifts were referenced to external CFCl 3 (0.0 ppm).
11
B NMR spectra at 128 MHz were obtained on a spectrometer equipped with the appropriate decoupling accessories. All 11 B NMR chemical shifts were referenced to external BF 3 ·OEt 2 (0.0 ppm) with a negative sign indicating an upfield shift. Mass spectra of potassium 1,2,3-triazoletrifluoroborates were recorded on LCQ Fleet Ion Trap Mass Spectrometer (ESI-MS) using negative ESI mode at the mass spectrometry facilities in KIST-Gangneung Institute. IR spectra were obtained using Nicolet iS10 FT-IR spectrometer. Melting points were performed on recrystallized solids and recorded on Stanford Research Systems OptiMelt MPA100 melting point apparatus and are uncorrected. Commercially available reagents were used without purification unless noted otherwise.
General Procedure I (Preparation of Potassium NHeterobiaryltrifluoroborate, Table 2 ). To a solution of potassium iodophenyltrifluoroborate (0.5 mmol), CuI (10 mol %), DMEDA (20 mol %), and Cs 2 CO 3 (0.5 mmol) in DMSO (2 mL) was added corresponding N-heteroarenes (0.55 mmol) under atmospheric conditions. The reaction mixture was stirred in an oil bath at 120 o C. After completion of the reaction, the solvent was removed in vacuo at 60-70 o C. The residual product was dissolved in dry acetone (3 mL), and the insoluble salts were removed by filtration through Celite. The solvent was concentrated on a rotary evaporator. The addition of Et 2 O led to the precipitation of the product. The product was filtered and dried in vacuo to afford the desired product.
Potassium 4-(1H-pyrazol-1-yl)phenyltrifluoroborate (1a) . White solid; mp 250 .8, 136.9, 133.7, 130.2, 129.3, 123.1, 122.7, 121.7, 120.6, 111.4, 103 5, 143.8, 136.9, 133.1, 129.5, 129.4, 122.8, 122.4, 117.1, 101.6; 19 F NMR (376 MHz, acetone-d 6 ) δ −140.2;
11 B NMR (128 MHz, acetone-d 6 ) δ 3.61; FT-IR (ATR): 3034, 1606, 1593, 1577, 1421, 1356, 1216, 958, 894, 830, 792, 771, 713 cm : 3062, 2926, 1605, 1515, 1464, 1422, 1379, 1223, 1199, 1023, 965, 905, 828, 737 cm 3031, 2928, 1601, 1502, 1452, 1211, 1069, 1007, 953, 828, 784, 766, 742 cm 13 C NMR (100 MHz, acetone-d 6 ) δ 165. 6, 137.9, 136.4, 135.3, 133.9, 127.9, 124.0, 123.6, 122.9, 122.2, 112.3, 108.7, 51 Table 3 ). To a solution of potassium 4-(1H-pyrazol-1-yl)phenyltrifluoroborate (0.3 mmol), Cs 2 CO 3 (0.9 mmol), Pd(TPP) 4 (5 × 10 −3 mmol, 5 mol %) in methanol (2 mL) was added aryl bromide (0.33 mmol). The reaction was conducted at 80 o C. After the reaction was finished, water (5 mL) was added and organic layer was extracted with EtOAc (5 mL × 3). The crude product was purified by column chromatography to give pure product.
1-(Biphenyl-4-yl)-1H-pyrazole (2a 2, 140.1, 139.4, 139.4, 128.9, 128.1, 127.5, 127.0, 127.0, 119.5, 107.7; FT-IR (ATR): 3130, 3107, 2923 , 2853 , 1607 , 1528 , 1484 , 1393 , 1332 2, 139.3, 139.2, 137.3, 129.6, 128.1, 127.8, 126.8, 126.5, 119.5, 107.7, 21.1; FT-IR (ATR): 3110, 3033, 2915 , 2856 , 1610 , 1515 , 1497 , 1393 , 1050 7, 141.6, 140.2, 137.9, 129.7 (q, J = 32.0 Hz), 128.4, 127.4, 126.9, 126 .0 (q, J = 3.7 Hz), 124.4 (q, J = 270.0 Hz), 119.7. 108.1; FT-IR (ATR): 3136, 2923 , 1606 , 1392 , 1328 , 1165 , 1108 , 1075 , 1047 5, 141.6, 140.4, 137.1, 132.7, 128.3, 127.5, 126.8, 119.5, 118.9, 111.1, 108.2; FT-IR (ATR): 3150, 3134, 3053, 2923 , 2852 , 2225 , 1604 , 1526 , 1493 , 1435 , 1388 , 1333 , 1034 147.5, 142.4, 141.2, 140.6, 134.7, 129.8, 126.9, 124.9, 120.9, 117.9, 117.6, 108.6, 107.7, 101.3, 29.7; FT-IR (ATR): 2924 , 2853 , 2359 , 2341 , 1586 , 1519 , 1506 , 1468 , 1242 , 1222 , 1040 8, 142.7, 141.6, 141.2, 140.5, 129.8, 129.1, 128.8, 126.9, 125.3, 119.7, 118.2, 118.1, 109.3, 107.7, 61.9, 55.5; FT-IR (ATR): 3386, 2925 , 2854 , 2360 , 2342 , 1605 , 1572 , 1518 , 1397 , 1218 , 1083 , 1044 4,4'-Di(1H-pyrazol-1-yl)biphenyl (3). To a solution of potassium 4-(1H-pyrazol-1-yl)phenyltrifluoroborate (75.0 mg, 0.3 mmol), Cs 2 CO 3 (293.2 mg, 0.9 mmol) and Pd(TPP) 4 (17.3 mg, 5 × 10 −3 mmol, 5 mol %) was added dry methanol (2 mL). The reaction was conducted at 80 o C. After 1 h, the solvent was removed under vacuum. After the reaction was finished, water (5 mL) was added and organic layer was extracted with EtOAc (5 mL × 3). The crude product was purified by column chromatography to give pure product (77.3 mg, a white solid) in 90% yield; mp 249. 2, 139.5, 138.2, 127.9, 126.7, 119.5, 107.8; FT-IR (ATR): 3135, 3119, 1608 , 1518 , 1498 , 1390 , 1332 , 1049 + 287.12, found 287.10. 1-(4-Iodophenyl)-1H-pyrazole (4). To a solution of potassium 4-(1H-pyrazol-1-yl)phenyltrifluoroborate (75.0 mg, 0.3 mmol) in THF and H 2 O (1 mL, respectively) were added NaI (45.0 mg, 0.3 mmol) and Chloroamine-T (84.5 mg, 0.3 mmol). The reaction mixture was stirred at rt for 1 h. The aqueous layer was extracted with EtOAc (5 mL × 3). The EtOAc layer was dried (Na 2 SO 4 ) and concentrated. The crude product was purified by column chromatography to give pure product (72.9 mg, a white solid) in 90% yield; mp 89. 4, 139.9, 138.4, 126.6, 120.8, 108.1, 90.5; FT-IR (ATR): 3149, 3087, 2923 , 2852 , 1585 , 1517 , 1487 , 1396 , 1386 , 1334 , 1307 , 1248 , 1197 , 1121 , 1000 ; ESIMS: m/z calcd for C 9 H 8 IN 2 [M+H] + 270.97, found 271.10. 4-(1H-Pyrazol-1-yl)phenol (5). To a solution of potassium 4-(1H-pyrazol-1-yl)phenyltrifluoroborate (75.0 mg, 0.3 mmol) in acetone and H 2 O (0.5 mL, respectively) was added Oxane (184.4 mg, 0.3 mmol). The reaction mixture was stirred at rt for 5 min. The aqueous layer was extracted with EtOAc (5 mL × 3). The EtOAc layer was dried (Na 2 SO 4 ) and concentrated. The crude product was purified by column chromatography to give pure product (47.1 mg, pale yellow oil) in 98% yield; 140.5, 133.3, 127.7, 121.8, 116.2, 107.2; FT-IR (ATR): 3425, 2922 , 2359 , 1600 , 1524 , 1462 , 1402 , 1274 , 1123 , 1083 
